The Danish pharmaceutical company Ferring Pharmaceuticals is building a new biotech centre at its headquarters in Switzerland, focusing on research and development.
The innovative and research-oriented global company, headquartered in Saint-Prex on Lake Geneva, specializes in reproductive medicine, among other things, and continuously develops new active ingredients to support women who wish to have children. The announcement of the creation of new jobs has been well received in the media, as an NZZ company portrait shows. In addition, a study was recently completed which, in cooperation with the WHO, aims to establish a new treatment to reduce postnatal bleeding in women.
Life Science Communication accompanies the company in its strategic media work with the help of the international agency network.